[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"doc-seo-340319-105":3,"detail-sidebar-cat-0-en-105":81,"doc-detail-340319-en":130},{"code":4,"msg":5,"data":6},0,"ok",{"site_id":7,"language":8,"slug":9,"title":10,"keywords":11,"description":12,"schema_data":13,"social_meta":74,"head_meta":76,"extra_data":78,"updated_unix":80},105,"en","the-role-of-sting-mediated-activation-of-dendritic-cells-in-cancer-immunotherapy","The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy","","The review explains how the cGAS–STING signaling axis, driven by cyclic GMP-AMP synthase and the STING receptor, functions as an actionable immunotherapy target, particularly through tumor-resident dendritic cells (DCs). It details how STING can trigger DNA-sensing events that produce pro-inflammatory mediators, prime effector T cells, and shape antitumor immunity. Evidence also shows a dual outcome in cancer, influenced by cell type and by acute versus chronic activation modes.",{"@graph":14,"@context":73},[15,34,56],{"@type":16,"itemListElement":17},"BreadcrumbList",[18,23,27,31],{"item":19,"name":20,"@type":21,"position":22},"https://docshare.wps.com","Home","ListItem",1,{"item":24,"name":25,"@type":21,"position":26},"https://docshare.wps.com/document/","Document",2,{"item":28,"name":29,"@type":21,"position":30},"https://docshare.wps.com/document/research-report/","Research & Report",3,{"item":32,"name":10,"@type":21,"position":33},"https://docshare.wps.com/document/the-role-of-sting-mediated-activation-of-dendritic-cells-in-cancer-immunotherapy/340319/",4,{"url":32,"name":10,"@type":35,"image":36,"author":41,"headline":10,"publisher":44,"fileFormat":47,"inLanguage":8,"description":12,"dateModified":48,"datePublished":49,"encodingFormat":47,"isAccessibleForFree":50,"interactionStatistic":51},"DigitalDocument",{"url":37,"@type":38,"width":39,"height":40},"https://docshare.wps.com/thumbnails/the-role-of-sting-mediated-activation-of-dendritic-cells-in-cancer-immunotherapy/340319.png","ImageObject",300,407,{"name":42,"@type":43},"Skyler","Person",{"url":19,"name":45,"@type":46},"DocShare","Organization","application/pdf","2026-11-01","2026-09-22",true,{"@type":52,"interactionType":53,"userInteractionCount":55},"InteractionCounter",{"@type":54},"ViewAction",8,{"@type":57,"mainEntity":58},"FAQPage",[59,65,69],{"name":60,"@type":61,"acceptedAnswer":62},"What does the cGAS–STING signaling pathway contribute to cancer immunotherapy?","Question",{"text":63,"@type":64},"It acts as an innate DNA-sensing mechanism that can promote inflammatory signaling, prime T cells, and support antitumor responses. The review frames this pathway as a druggable target for immunotherapy.","Answer",{"name":66,"@type":61,"acceptedAnswer":67},"Why can STING activation have both antitumor and tumor-promoting effects?",{"text":68,"@type":64},"The review states the outcome depends on the cell type where cGAS–STING signaling is induced and on whether activation is acute or chronic. This context creates a functional dichotomy in cancer.",{"name":70,"@type":61,"acceptedAnswer":71},"How does STING activation in dendritic cells influence tumor eradication?",{"text":72,"@type":64},"The review highlights that STING activation at the DC level appears particularly important for tumor eradication. It connects DC subset activity and STING-driven mechanisms to antitumor immunity in tumor tissue.","https://schema.org",{"og:url":32,"og:type":75,"og:title":10,"og:site_name":45,"og:description":12},"article",{"robots":77,"canonical":32},"index,follow",{"doc_id":79,"site_id":7},340319,1790571766,{"code":4,"msg":82,"data":83},"success",[84,88,92,96,101,106,111,114,119,122,126],{"id":22,"doc_module":4,"doc_module_name":25,"category_name":85,"show_sort_weight":86,"slug":87},"Story & Novel",90,"story-novel",{"id":26,"doc_module":4,"doc_module_name":25,"category_name":89,"show_sort_weight":90,"slug":91},"Literature",80,"literature",{"id":33,"doc_module":4,"doc_module_name":25,"category_name":93,"show_sort_weight":94,"slug":95},"Exam",70,"exam",{"id":97,"doc_module":4,"doc_module_name":25,"category_name":98,"show_sort_weight":99,"slug":100},5,"Comic",60,"comic",{"id":102,"doc_module":4,"doc_module_name":25,"category_name":103,"show_sort_weight":104,"slug":105},6,"Technology",50,"technology",{"id":107,"doc_module":4,"doc_module_name":25,"category_name":108,"show_sort_weight":109,"slug":110},7,"Healthcare",40,"healthcare",{"id":55,"doc_module":4,"doc_module_name":25,"category_name":29,"show_sort_weight":112,"slug":113},30,"research-report",{"id":115,"doc_module":4,"doc_module_name":25,"category_name":116,"show_sort_weight":117,"slug":118},9,"Religion & Spirituality",20,"religion-spirituality",{"id":117,"doc_module":4,"doc_module_name":25,"category_name":120,"show_sort_weight":117,"slug":121},"World Cup","world-cup",{"id":123,"doc_module":4,"doc_module_name":25,"category_name":124,"show_sort_weight":123,"slug":125},10,"Lifestyle","lifestyle",{"id":127,"doc_module":4,"doc_module_name":25,"category_name":128,"show_sort_weight":97,"slug":129},19,"General","general",{"code":4,"msg":82,"data":131},{"doc_id":79,"user_id":132,"nickname":42,"user_avatar":133,"doc_module":4,"category_id":55,"category_name":29,"doc_title":10,"doc_description":12,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":55,"is_deleted":4,"is_public":22,"is_downloadable":22,"audit_status":22,"page_count":139,"language":140,"language_code":8,"site_id":7,"html_lang":8,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":12,"update_tm":144,"read_time":145,"preview_page_count":33,"preview_urls":146},2336464648746,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","International Journal of Nanomedicine Dovepress  \n Open Access Full Text Article REVIEW  \nThe Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy  \nAna RS Ribeiro 1 , 2 , Theresa Neuper 1–3 , Jutta Horejs-Hoeck 1–3  \n1Department of Biosciences and Medical Biology, Paris Lodron University of Salzburg, Salzburg, Austria; 2Cancer Cluster Salzburg (CCS), Salzburg, 5020, Austria; 3Center for Tumor biology and Immunology (CTBI), Salzburg, 5020, Austria  \nCorrespondence: Jutta Horejs-Hoeck, Department of Biosciences and Medical Biology, Paris-Lodron University Salzburg, Hellbrunner Strasse 34, Salzburg, 5020, Austria, Tel +43(0)662 8044 5709, Email [jutta.horejs-hoeck@plus.ac.at](jutta.horejs-hoeck@plus.ac.at)  \n\n| Abstract: The signaling pathway that comprises cyclic guanosine monophosphate–adenosine monophosphate (cGAMP or GMPAMP) synthase (cGAS) and Stimulator of Interferon Genes (STING) is emerging as a druggable target for immunotherapy, with tumor-resident dendritic cells (DC) playing a critical role in mediating its effects. The STING receptor is part of the DNA-sensing cellular machinery, that can trigger the secretion of pro-inflammatory mediators, priming effector T cells and initiating specific antitumor responses. Yet, recent studies have highlighted the dual role of STING activation in the context of cancer: STING can either promote antitumor responses or enhance tumor progression. This dichotomy often depends on the cell type in which cGAS-STING signaling is induced and the activation mode, namely acute versus chronic. Of note, STING activation at the DC level appears to be particularly important for tumor eradication. This review outlines the contribution of the different conventional and plasmacytoid DC subsets and describes the mechanisms underlying STING-mediated activation of DCs in cancer. We further highlight how the STING pathway plays an intricate role in modulating the function of DCs embedded in tumor tissue. Additionally, we discuss the strategies being employed to harness STING activation for cancer treatment, such as the development of synthetic agonists and nano-based delivery systems, spotlighting the current techniques used to prompt STING engagement specifically in DCs.\u003Cbr>Keywords: dendritic cell, cGAS-STING pathway, cancer immunotherapy, nanoparticle |\n| --- |\n| Introduction\u003Cbr>The paradigm of natural antitumor immunity involves the recognition, processing and presentation of cancer-associated antigens by dendritic cells (DCs) on major histocompatibility (MHC) complexes, triggering effective T cell-mediated antitumor immunity that results in killing of the cancer cells.1–4 Accordingly, DCs are highly specialized tissue-scanning cells equipped with a plethora of receptors to detect damage- or pathogen-associated molecular patterns (DAMPs or PAMPs) . Although the immune system’s task of filtering and responding to onco-signals emanating from cancerous tissue is an exceedingly complex one, the wide range of innate receptors expressed by DCs enables them to effectively recognize several by-products associated with tumor growth, such as tumor-derived DNA present in the tumor microenvironment (TME) .5–7 The cGAS-STING pathway is an innate DNA-sensing mechanism which was originally described to mediate protective immune responses against infections but was recently found to play a crucial role in driving antitumor immunity. In particular, activation of STING signaling in DCs has the potential to generate spontaneous as well as long-lasting and highly specific antitumor immunity.8–10 This review focuses on the contribution of individual DC subsets to cancer defense and explores emerging developments in STING-mediated activation of DCs for novel cancer therapeutics.\u003Cbr>The cGAS-STING Pathway and Its Effects in Cancer Cells\u003Cbr>The cGAS-cGAMP-STING signaling pathway, discovered in 2013, is a promising therapeutic target to enhance antitumor immunity. Its activation induces an inflammato","cbCaiuHX9P3sp5ks","https://ap.wps.com/l/cbCaiuHX9P3sp5ks","pdf",1760591,13,"English","# Abstract\n# Introduction\n## DC recognition of tumor-associated antigens and danger signals\n# The cGAS–STING Pathway and Its Effects in Cancer Cells\n## Mechanistic activation steps and downstream signaling\n# Immunotherapy implications","[{\"question\":\"What does the cGAS–STING signaling pathway contribute to cancer immunotherapy?\",\"answer\":\"It acts as an innate DNA-sensing mechanism that can promote inflammatory signaling, prime T cells, and support antitumor responses. The review frames this pathway as a druggable target for immunotherapy.\"},{\"question\":\"Why can STING activation have both antitumor and tumor-promoting effects?\",\"answer\":\"The review states the outcome depends on the cell type where cGAS–STING signaling is induced and on whether activation is acute or chronic. This context creates a functional dichotomy in cancer.\"},{\"question\":\"How does STING activation in dendritic cells influence tumor eradication?\",\"answer\":\"The review highlights that STING activation at the DC level appears particularly important for tumor eradication. It connects DC subset activity and STING-driven mechanisms to antitumor immunity in tumor tissue.\"}]","The Role of STING-Mediated Activation of Dendritic Cells in Cancer Immunotherapy | PDF",1790035769,33,[147,151,155,159],{"page_no":22,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/92d526b914cc2e6db6049137f6ecea66.webp",983,1272,{"page_no":26,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ec580ece0dd3c4e4551d48a12fa8de2d.webp",982,1270,{"page_no":30,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f5e7971b142ff3054ee34238e131e8a6.webp",981,1269,{"page_no":33,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/7f7ca61a4b909ae5983fe7ca20e1103d.webp",980,1268]